Genflow Biosciences PLC (LSE:GENF) founder and chief executive Dr Eric Leire joins Proactive London to provide an update to investors four months after the long-life company’s initial public offer in London.
He talks about the company’s cash runway to enable it to weather the current market storm, how it is “a beautiful position” in relation to opportunities in the biotech sector, and the importance of Genflow’s current pre-clinical work.